Answer
After intravitreal injection, brolucizumab has an apparent systemic half-life of 4.3 ± 1.9 days.
Sources for this answer
- Beovu 120 mg/ml solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 12Document updated
Sources checked